This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEBBR0PM_M.jpg
Medtronic announced earnings per share of $0.58 on revenue of $6.00B. Analysts polled by Investing.com anticipated EPS of $1.08 on revenue of $7.11B. That with comparison to EPS of $1.54 on revenue of $8.15B in the same period a year before. Medtronic had reported EPS of $1.44 on revenue of $7.72B in the previous quarter. Analysts are expecting EPS of $0.8 and revenue of $6.39B in the upcoming quarter.
Medtronic shares are down 13% from the beginning of the year , still down 19.71% from its 52 week high of $122.15 set on January 22. They are under-performing the S&P 500 which is down 8.42% year to date.
Medtronic’s report follows an earnings beat by Novartis ADR on April 28, who reported EPS of $1.56 on revenue of $12.28B, compared to forecasts EPS of $1.39 on revenue of $12B.
Pfizer had beat expectations on April 28 with first quarter EPS of $0.8 on revenue of $12.03B, compared to forecast for EPS of $0.73 on revenue of $11.81B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
